Top Markets
Coin of the day
Maxigen Biotech Inc. Maxigen Biotech Inc.

Maxigen Biotech Inc.

1783
Rang in Aktien #21088
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development,... Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Aktienkurs
$1.28
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$115.23M
Veränderung (1 Tag)
-0.25%
Veränderung (1 Jahr)
-10.17%
Land
TW
Handel Maxigen Biotech Inc. (1783)

Kategorie

Preis 1783 mit Marktkapitalisierung von B
Maxigen Biotech Inc. Maxigen Biotech Inc.
1783
$1.28
Marktkapitalisierung von Maxigen Biotech Inc.(1783)
Marktkapitalisierung: $115.23M
Mit Stand August 2026 hat Maxigen Biotech Inc. eine Marktkapitalisierung von $115.23M. Das macht Maxigen Biotech Inc. laut unseren Daten zum 21088th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Maxigen Biotech Inc. von 2012 bis 2026
1783 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 1783 Vermögenswert B Marktkapitalisierung von B Ergebnisse
Maxigen Biotech Inc. Maxigen Biotech Inc.
$58,099.29 $115.23M
$5.211T +4,522,369.46%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$50,689.70 $115.23M
$4.547T +3,945,604.16%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$46,405.64 $115.23M
$4.162T +3,612,131.42%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$40,054.47 $115.23M
$3.593T +3,117,753.81%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$31,136.32 $115.23M
$2.793T +2,423,562.31%